A PHASE II STUDY OF S-1 FOR PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Fukuda, M. [1 ,3 ]
Kasai, T. [2 ]
Fukuda, M. [1 ,3 ]
Nakamura, Y. [4 ]
Soejima, Y. [5 ]
Takatani, H. [1 ]
Nakatomi, K. [4 ]
Kinoshita, A. [6 ]
Oka, M. [7 ]
Kohno, S.
机构：
[1] Japanese Red Cross Nagasaki Atom Bomb Hosp, Nagasaki, Japan
[2] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan
[3] Nagasaki Municipal Hosp, Nagasaki, Japan
[4] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
[5] Natl Hosp Org, Ureshino Med Ctr, Ureshino, Japan
[6] NHO Nagasaki Med Ctr, Ohmura, Japan
[7] Kawasaki Med Sch, Div Resp Dis, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [21] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Yoshikazu Hasegawa
    Isamu Okamoto
    Ken Takezawa
    Masaaki Miyazaki
    Junji Tsurutani
    Kimio Yonesaka
    Ryotaroh Morinaga
    Asuka Tsuya
    Masaaki Terashima
    Toshihiro Kudoh
    Koichi Azuma
    Takayasu Kurata
    Tatsuyuki Nishikawa
    Masahiro Fukuoka
    Yasumasa Nishimura
    Kazuhiko Nakagawa
    Investigational New Drugs, 2013, 31 : 599 - 604
  • [22] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Hasegawa, Yoshikazu
    Okamoto, Isamu
    Takezawa, Ken
    Miyazaki, Masaaki
    Tsurutani, Junji
    Yonesaka, Kimio
    Morinaga, Ryotaroh
    Tsuya, Asuka
    Terashima, Masaaki
    Kudoh, Toshihiro
    Azuma, Koichi
    Kurata, Takayasu
    Nishikawa, Tatsuyuki
    Fukuoka, Masahiro
    Nishimura, Yasumasa
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 599 - 604
  • [23] Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601
    Akie, Kenji
    Oizumi, Satoshi
    Ogura, Shigeaki
    Shinagawa, Naofumi
    Kikuchi, Eiki
    Fukumoto, Shinichi
    Harada, Masao
    Kinoshita, Ichiro
    Kojima, Tetsuya
    Harada, Toshiyuki
    Fujita, Yuka
    Ohsaki, Yoshinobu
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ONCOLOGY, 2011, 81 (02) : 84 - 90
  • [24] Phase I study of irinotecan and gemcitabine in previously untreated, patients with advanced non-small cell lung cancer
    Takatani, Hiroshi
    Soda, Hiroshi
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Nagashima, Seiji
    Fukuda, Minoru
    Soejima, Yoshifumi
    Nakano, Hirofumi
    Oka, Mikio
    Kohno, Shigeru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (05) : 353 - 357
  • [25] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Nanae Tomonaga
    Yoichi Nakamura
    Hiroshi Soda
    Seiji Nagashima
    Hirofumi Nakano
    Akitoshi Kinoshita
    Masaaki Fukuda
    Minoru Fukuda
    Hiroshi Takatani
    Yoshifumi Soejima
    Mikio Oka
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 43 - 49
  • [26] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Tomonaga, Nanae
    Nakamura, Yoichi
    Soda, Hiroshi
    Nagashima, Seiji
    Nakano, Hirofumi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Fukuda, Minoru
    Takatani, Hiroshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 43 - 49
  • [27] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Satoshi Yoda
    Kenzo Soejima
    Hiroyuki Yasuda
    Katsuhiko Naoki
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Ryosuke Satomi
    Sohei Nakayama
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Maiko Morosawa
    Koichiro Asano
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 717 - 722
  • [28] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Yoda, Satoshi
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Naoki, Katsuhiko
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Satomi, Ryosuke
    Nakayama, Sohei
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Morosawa, Maiko
    Asano, Koichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 717 - 722
  • [29] Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer
    Goya, Hiroki
    Kuraishi, Hiroshi
    Koyama, Shigeru
    Ichiyama, Takashi
    Yoshiike, Fumiaki
    Hirai, Kazuya
    Agatsuma, Toshihiko
    Tateishi, Kazunari
    Kanda, Shintaro
    Yamamoto, Hiroshi
    Kubo, Keishi
    Koizumi, Tomonobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 691 - 697
  • [30] Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer
    Hiroki Goya
    Hiroshi Kuraishi
    Shigeru Koyama
    Takashi Ichiyama
    Fumiaki Yoshiike
    Kazuya Hirai
    Toshihiko Agatsuma
    Kazunari Tateishi
    Shintaro Kanda
    Hiroshi Yamamoto
    Keishi Kubo
    Tomonobu Koizumi
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 691 - 697
12345